Tomoyasu Jo

Kawahara, 6068507, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Correction to: Low reticulocyte count at infusion is a risk factor for high-grade cytokine release syndrome in chimeric antigen receptor T cell therapy.

Correction to: Low reticulocyte count at infusion is a risk factor for high-grade cytokine release syndrome in chimeric antigen receptor T cell therapy.

Journal: International journal of hematology

Published: June 25, 2026

Usefulness of pegfilgrastim for allogeneic peripheral blood stem cell collection from healthy donors.

Usefulness of pegfilgrastim for allogeneic peripheral blood stem cell collection from healthy donors.

Journal: Transfusion

Published: March 24, 2026

Prolonged Cytokine Release Syndrome is Associated with Hypofibrinogenemia after CD19-Directed CAR T-Cell Therapy in Adult Patients with Relapsed/Refractory Lymphoma.

Prolonged Cytokine Release Syndrome is Associated with Hypofibrinogenemia after CD19-Directed CAR T-Cell Therapy in Adult Patients with Relapsed/Refractory Lymphoma.

Journal: Transplantation and cellular therapy

Published: March 04, 2026

Absence of Pretransplant Peripheral Blasts Is a Favorable Factor in Allogeneic Stem Cell Transplantation for Advanced Acute Lymphoblastic Leukemia.

Absence of Pretransplant Peripheral Blasts Is a Favorable Factor in Allogeneic Stem Cell Transplantation for Advanced Acute Lymphoblastic Leukemia.

Journal: Transplantation and cellular therapy

Published: February 22, 2026

Decreased renal function predicts severe cytokine release syndrome after CAR-T-cell therapy for large B-cell lymphoma.

Decreased renal function predicts severe cytokine release syndrome after CAR-T-cell therapy for large B-cell lymphoma.

Journal: British journal of haematology

Published: February 03, 2026

Schnitzler Syndrome as an Autoinflammatory Disease Driven by B-Cell-Specific Somatic MYD88 Mutation.

Schnitzler Syndrome as an Autoinflammatory Disease Driven by B-Cell-Specific Somatic MYD88 Mutation.

Journal: Allergy

Published: January 15, 2026

Drivers of temporal improvement in CAR T-cell therapy for large B-cell lymphoma: a Japanese nationwide registry analysis.

Drivers of temporal improvement in CAR T-cell therapy for large B-cell lymphoma: a Japanese nationwide registry analysis.

Journal: Blood advances

Published: December 24, 2025

Low reticulocyte count at infusion is a risk factor for high-grade cytokine release syndrome in chimeric antigen receptor T cell therapy.

Low reticulocyte count at infusion is a risk factor for high-grade cytokine release syndrome in chimeric antigen receptor T cell therapy.

Journal: International journal of hematology

Published: October 04, 2025

CAR-T cell therapy in clinical practice

CAR-T cell therapy in clinical practice

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: October 01, 2025

Low reticulocyte count at infusion is a risk factor for ICANS in CAR-T cell therapy.

Low reticulocyte count at infusion is a risk factor for ICANS in CAR-T cell therapy.

Journal: Cytotherapy

Published: September 07, 2025

Impact of CD34+ cell dose on outcomes of related allogeneic PBSCT in adult AML patients.

Impact of CD34+ cell dose on outcomes of related allogeneic PBSCT in adult AML patients.

Journal: British journal of haematology

Published: July 20, 2025

Impact of methotrexate-dosing regimens for GVHD prophylaxis on clinical outcomes of HLA-matched allogeneic HSCT.

Impact of methotrexate-dosing regimens for GVHD prophylaxis on clinical outcomes of HLA-matched allogeneic HSCT.

Journal: British journal of haematology

Published: May 26, 2025

Showing 1-12 of 60

Last Updated: 09/26/2026